MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
OPKO Health DIO Ratio 2011-2026 | OPK
Annual DIO Ratio OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45.2 | 46.8 | 40.9 | - | - | 34.1 | 25.5 | 29 | 28.2 | 61.6 | 126 | 135 | 291 | 282 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 291 | 25.5 | 95.5 |
Quarterly DIO Ratio OPKO Health
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55.4 | 52.5 | - | 41.8 | 44.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 251 | 249 | - | 136 | 121 | 128 | - | 138 | 126 | 157 | - | 271 | 310 | 326 | - | 303 | 249 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 326 | 41.8 | 174 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
243 | $ 24.45 | 4.28 % | $ 263 M |  China |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Co-Diagnostics
CODX
|
304 | $ 6.05 | 1.09 % | $ 178 M | USA |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
Castle Biosciences
CSTL
|
48.7 | $ 39.32 | -0.86 % | $ 1.09 B | USA |
 |
DexCom
DXCM
|
119 | $ 69.4 | -2.23 % | $ 26.8 B | USA |
 |
BioNano Genomics
BNGO
|
245 | $ 1.6 | 0.63 % | $ 2.03 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
78.4 | $ 105.93 | -1.52 % | $ 13 B | USA |
 |
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
Illumina
ILMN
|
137 | $ 147.9 | 1.61 % | $ 23.5 B | USA |
 |
CareDx, Inc
CDNA
|
48.3 | $ 20.33 | -1.19 % | $ 1.09 B | USA |
 |
Danaher Corporation
DHR
|
92.9 | $ 239.32 | 0.11 % | $ 175 B | USA |
 |
DarioHealth Corp.
DRIO
|
165 | $ 12.33 | 5.61 % | $ 350 M |  Israel |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
44.2 | $ 66.82 | -0.98 % | $ 4.62 B | USA |
 |
Exact Sciences Corporation
EXAS
|
240 | $ 102.16 | -0.07 % | $ 18.9 B | USA |
 |
Fulgent Genetics
FLGT
|
7.17 | $ 28.28 | 0.44 % | $ 855 M | USA |
 |
Aspira Women's Health
AWH
|
23.1 | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
35.8 | $ 6.54 | -0.46 % | $ 593 M | USA |
 |
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | Israel |
 |
Natera
NTRA
|
25.8 | $ 235.34 | -0.05 % | $ 23.2 B | USA |
 |
Pacific Biosciences of California
PACB
|
132 | $ 2.11 | 4.98 % | $ 535 M | USA |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 226.77 | 3.57 % | $ 11.7 B | USA |
 |
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | USA |
 |
Personalis
PSNL
|
12.1 | $ 8.54 | -0.35 % | $ 506 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | USA |
 |
Mettler-Toledo International
MTD
|
79 | $ 1 506.5 | 0.94 % | $ 32 B |  Schweiz |
 |
ENDRA Life Sciences
NDRA
|
405 | $ 4.41 | -2.22 % | $ 2.37 M | USA |
 |
Invitae Corporation
NVTA
|
126 | - | - | $ 21.2 M | USA |
 |
Neogen Corporation
NEOG
|
147 | $ 9.23 | -1.49 % | $ 2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
10.4 | $ 176.78 | 0.98 % | $ 19.6 B | USA |
 |
Organovo Holdings
ONVO
|
371 | - | -2.3 % | $ 19.4 M | USA |